The Science of Protected

Similar documents
EQUINE VACCINATION AN EDUCATIONAL GUIDE FOR HORSE OWNERS.

VACCINATIONS FOR FOALS

UPDATE ON EQUINE VACCINATION PROGRAMS

EHV (Equine Herpes Virus) Management

Disease Prevention in Horses

Equine Vaccination Recommendations

EQUINE DISEASES AND VACCINES

EQUINE DISEASES AND GUIDELINES

THAL EQUINE LLC Regional Equine Hospital Horse Owner Education & Resources Santa Fe, New Mexico

One of the brightest spots of equine medical care for horses

Equine Vaccines. Bailee Stanton, DVM Moore Equine Veterinary Center

Mountain Pointe s Disease and Vaccine Series By Amber Rieser

salmonella abortus-equi

Infectious Upper Respiratory Tract Disease in Horses

CUSTOMIZE YOUR HORSE S VACCINATION

Vaccinations. Vaccination Chart At Bottom Of Page

September 24, Dr. Amanda House: As far as I am aware, there are no definitive ante-mortem diagnostic tests for rabies in the horse.

Vaccination Guidelines - AAEP

Equine Diseases. D. Karen Hansen, PhD 2001 University of Wyoming Stephen R. Schafer, EdD 2006 University of Wyoming

Pennsylvania Department of Agriculture. Edward G. Rendell, Governor Dennis C Wolff, Secretary

Equine Herpesvirus (EHV) Myeloencephalopathy

The Florida Department of Agriculture and Consumer Services. Past Events Present Accomplishments Future Opportunities

EHV1 outbreak Diagnosis and epidemiology

Equine Science & Technology. Unit Title: Equine Diseases CIP:

GUIDELINES FOR THE VACCINATION OF DOGS

MPI is satisfied the current quarantine measures in place are sufficient to manage the situation.

Barn Air Quality and Transmissible Disease Protection

THE NEXT GENERATION CIRCUMVENT G2 GIVES YOU EVEN MORE PCV2 OPTIONS!

MORE THAN JUST FOOTBATHS: PRACTICAL EQUINE BIOSECURITY

B. PACKAGE LEAFLET 1

ADDRESSING CIV IN YOUR FACILITY Your guide to the prevention and management of canine influenza virus (CIV) and other infectious respiratory diseases

The protective power of vaccination

AAEP Vaccination Guidelines

NEW: USEF Vaccination Rule

U.S. Readiness for Pandemics

certificate, the horses will be returned or destroyed by AQSIQ. Article 2 Article 3 Article 4 Article 5

UPDATE ON CANINE INFLUENZA IN TENNESSEE. Staci Cannon, DVM, MPH, DACVPM, DABVP (Shelter Medicine Practice)

Economics of Vaccine Development A Vaccine Manufacturer s Perspective

Arbovirus Infections and the animal reservoir

Northern aquaculture; modern vaccine- and gene technology giving health and welfare to the fish and well-being to the farmer

at a glance

The protective power of vaccination

UPDATE on VACCINE ISSUES. W. Jean Dodds, DVM

What Animal Shelters Need to Know About the Canine Influenza Outbreak. Thanks! Canine Influenza: Background

Frequently Asked Questions about Canine Influenza H3N2

The OIE World Animal Health and Welfare Fund

guidelines types Why change? This is a disturbing trend.

STRANGLES. Strangles is a highly contagious disease. Rutgers Equine Research Updates: NJDA s New Test Cuts CEM Quarantine Time, Expense 5.

The NEXT GENERATION Circumvent G2 gives you even more PCV2 OPTIONS! THE NEXT GENERATION THE SCIENCE OF HEALTHIER ANIMALS

Introduction: Goals and expectations of vaccination programs in beef cattle intended for show purposes

Analysis of Recombinant Canarypox Vectored West Nile Virus Vaccine Stability Post- Reconstitution

Test list Group Test Method Sample. Infectious diseases - Bacteria

FOR THE PERMANENT IMPORT OF HORSES INTO THE UNITED ARAB EMIRATES FROM JAPAN

M. hyo. M. hyo. M. hyo. Single injection. Double protection. Ready-to-use protection against both PCV2 and M. hyo. It s easy. It works.

MATERIAL SAFETY DATA SHEET SECTION 1. IDENTIFICATION OF SUBSTANCE AND CONTACT INFORMATION. ENCEVAC T + WNV with HAVLOGEN

YOU NEED CHOICES. Elanco now brings you a comprehensive line of cattle vaccine health management solutions for your operation.

The Science of Palatability

2015 JUNIOR DISEASES

Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines

Vaccination-Strategies

SUMMARY OF PRODUCT CHARACTERISTICS

Infectious Disease Updates

More thoughts on EHV-1. Dr. Christine King

INTERNATIONAL COLLATING CENTRE

CLINICAL RELEVANCE. D. A. Grosenbaugh, DVM, PhD a C. S. Backus, DVM, PhD b K. Karaca, DVM, PhD a J. M. Minke, DVM, PhD c R. M. Nordgren, DVM, PhD a

Serologic Responses to Eastern and Western Equine Encephalomyelitis Vaccination in Previously Vaccinated Horses*

Developing a Target Product Profile for a Preventive HIV Vaccine

Vaccinations 101. Article by Lisa Rodier from Whole Dog Journal, August 2008

VACCINES and VACCINATION: Change is in the WIND!

Mosquito Surveillance/Control in Texas

ARE YOU VACCINATING YOUR DOG TOO MUCH? A QUICK GUIDE TO COMPARING YOUR DOG S VACCINE SCHEDULE TO CURRENT RESEARCH.

Creative Giving Day Engagement. How to think outside the box and make the most of your Giving Day!


Zoetis will cover reasonable diagnostic and treatment costs up to $5,000 if a pet vaccinated with one of the Zoetis antigens listed below contracts

Session 1. The aims of immunisation, national policy and schedules. Quality Education for a Healthier Scotland

GENERAL SAFETY ISSUES September 18, 2009

Vaccines: Heroes or Villains?

How to Investigate a Disease Outbreak

The Top 10 Things You Should Know Before Choosing Your

SCIENTIFIC DISCUSSION

USDA APHIS One Health Initiative

One World One Health TM

Avian Influenza. Regional Workshops: Veterinary Discussion. Will Garton

Creative Engagement. Out of the box ideas to excite and engage supporters on your Giving Day!

The right choice for your health

Canine Influenza FAQ. Questions, Answers, and Interim Guidelines

Lessons Learnt Egypt FAO ECTAD EGYPT

The Science of Palatability

IIHF INFECTION CONTROL

Now with even more combinations, it s easier to find the best match for your operation.

Western Veterinary Conference 2013

Intercell and Novartis form world leading strategic partnership to drive vaccines innovation

Infectious bovine rhinotracheitis: causes, signs and control options

Control of Canine Influenza in Dogs Questions, Answers, and Interim Guidelines October 17, 2005

VEM 5503 Veterinary Epidemiology Sampling and sample size

This presentation is divided into two sections: 1. Global movements of horses 2. Global disease distribution

Nicola Pusterla, DMV, Diplomate ACVIM; Samantha Mapes, MS; and W. David Wilson, BVMS, MS MEDICINE INFECTIOUS DISEASES

2017 Kentucky Canine Influenza Outbreak UKVDL Survey of KVMA Member Practices, Jan-Aug, 2017

Should the US develop and Stockpile Vaccines and Antiviral Medications Against. A(H5N1) Avian Flu?

Proceedings of the Society for Theriogenology Annual Conference 2014

Transcription:

The Science of Protected Merck Animal Health Vaccine Collection

Our aim is to help horses live long, healthy and productive lives. Merck Animal Health OVER 70 YEARS of INNOVATIVE ANIMAL HEALTH SOLUTIONS Merck Animal Health has a rich history; it is a story of innovation, commitment to research and entrepreneurship in animal health, reaching back over 70 years. The establishment of the company was sparked by breakthrough ideas ideas from people with the intelligence and spirit to take on the diseases they saw harming animals, people, and livelihoods all around them. Now, this long-standing experience is helping to shape the future of animal health.

We are driven by PASSION FOR SCIENCE AND ANIMAL HEALTH Merck Animal Health is not just a company. It s where the science of healthy animals meets the commitment of horse health professionals. We work every day to bring you innovative products and trusted support. We are building on a rich history of providing animal health solutions. However, to help solve the challenges equine veterinarians face, we re not resting on our history alone. Merck Animal Health continues to make significant investments in research and development each year. The science behind our protection builds off a rich history of innovation but doesn t stop there. Our researchers are behind the scenes looking for tomorrow s solutions. We re listening to what horse owners are concerned with and anticipating tools veterinarians will need. I m proud of our portfolio today, and even more excited about how it will look in the future. Wendy E. Vaala, V.M.D., Dipl. ACVIM Merck Animal Health

We developed a VACCINE LINE THAT SETS THE STANDARD IN QUALITY & SAFETY Prestige PRESTIGE V + WNV PRESTIGE V + VEE PRESTIGE V PRESTIGE II PRESTIGE The Prestige line of equine vaccines help aid in prevention of many of the most common equine diseases, including eastern, western and Venezuelan encephalomyelitis, tetanus, equine influenza, equine herpesvirus and West Nile virus. Prestige vaccines are formulated to minimize reactions and maximize protection. Plus, multiple antigen combinations provide veterinarians the flexibility to create a customized vaccination program for each horse. FLU AVERT I.N. Only Flu Avert I.N. provides unparalleled influenza protection by stimulating local and systemic immunity. Intranasal administration provides a rapid onset of protection following a single dose for primary immunization in horses 11-months of age and older. Protection lasts a full 6-months, making it ideal for young horses, horses in training and horses that travel. PRODIGY Prodigy equine herpesvirus vaccine is recommended for pregnant mares as an aid in prevention of EHV-1 induced abortions. In fact, in a severe EHV-1 challenge study, Prodigy-vaccinated mares demonstrated 89.5% protection against abortions associated with EHV-1- induced infections and a 96.1% reduction in virus shedding. EQUIRAB The only rabies vaccine designed and labeled exclusively for the horse, EquiRab rabies vaccine delivers a long-lasting 14-month duration of immunity. Labeled for horses 4-months of age and older and requires just one dose for primary immunization. EquiRab was 97.7% reaction-free in field safety trials. EQUI-NILE For vaccination of healthy horses 6 month of age or older; as an aid in reduction of disease, encephalitis, and viremia caused by West Nile Virus. Equi-Nile uses killed-virus chimera technology for efficacy and safety. SUPER-TET Monovalent tetanus protection to give you flexibility and help protect horses from an unavoidable disease risk. Encevac ENCEVAC TC-4 + VEE ENCEVAC TC-4 ENCEVAC T + WNV ENCEVAC T + VEE ENCEVAC T The Encevac line of equine vaccines covers eastern, western and Venezuelan encephalomyelitis, tetanus, influenza and West Nile virus. Encevac vaccines have an exceptional safety profile in a variety of combinations to help protect every horse. Merck Vaccine Tetanus WNV Rabies EEE/WEE VEE Influenza EHV-1/EHV-4 EHV-1/Abortion and Respiratory Prestige V + WNV Prestige V + VEE Prestige V Prestige II Encevac TC-4 + VEE Encevac TC-4 Encevac T + WNV Encevac T + VEE Encevac T Equi-Nile Super-Tet EquiRab Prodigy Prestige Flu Avert I.N.

The only thing a vaccine should provide is protection. That s why Merck uses state-of-the-art technology in all its products to minimize risk of reactions and provide consistency in each and every dose. D. Craig Barnett, D.V.M. Merck Animal Health We deliver INNOVATION BACKED BY SCIENCE YOU CAN TRUST 3 2 1 2 Antigen Purification System A vaccine can never be too safe. Our technology, known as the Antigen Purification System (APS), has been utilized for more than 20 years to help remove extraneous protein and cellular debris. Using this method of filtration purification allows concentration of antigen; while minimizing the presence of extraneous protein and cellular debris that can contribute to vaccine associated adverse events. By purifying the vaccines with the APS, we reduce the debris that can cause undesirable injection site reactions in the horse. The microfilter (1) technology in the Merck APS helps purify the vaccine antigen (2) by filtering out unwanted extraneous proteins (3) that may be involved with injection site reactions. 2 1 Havlogen is a proprietary adjuvant that is comprised of a lipid-based, carbopol polymer cross-linking suspension (1) that, when combined with the antigen (2), enhances antigen presentation through the slow release and gradual absorption of the antigen. Exclusive Havlogen Adjuvant Our killed vaccines are highly efficacious, in part, because of our exclusive Havlogen adjuvant. Havlogen is an emulsive, lipid-based, carbopol polymer cross-linking adjuvant. Havlogen stimulates the immune system to produce high, long-lasting levels of protection through the slow release and gradual absorption of antigen. Due to the composition of Havlogen, the vaccine maintains suspension without separation and settling in the vial resulting in consistency and potency in every dose. By combining our APS system and Havlogen adjuvant, we are able to produce a line of killed virus vaccines that are highly efficacious and have an exceptional safety profile shown to be 98% reaction-free in field safety trials. 1 1 Data on File. Merck Animal Health.

We stand behind our VAC C I N E S WIT H C O N T I N UED SU P P O RT & E D U C AT I O N Vaccine Guarantee We stand behind our products. That s why we prove our commitment to the equine veterinarian, to the horse owner and, most of all, to the horse. Merck Animal Health will reimburse reasonable diagnostic and treatment costs, up to $5,500, for any horse properly vaccinated by a licensed veterinarian with one of our equine vaccines that contracts influenza, rabies, tetanus, West Nile virus, eastern, western or Venezuelan encephalomyelitis, or respiratory disease caused by equine herpesvirus 1 and/or 4. Biosurveillance Program The Merck Animal Health Equine Respiratory Biosurveillance Program offers participating veterinarians the information and tools to sample horses with clinical signs of upper respiratory disease, so they can provide the most accurate and timely diagnosis possible to their clients. Since 2008, we have been conducting this ongoing, voluntary equine biosurveillance program to study the prevalence and epidemiology of relevant viral and bacterial respiratory pathogens. During an acute infectious upper respiratory disease outbreak, an accurate and timely diagnosis is critical to ensure proper treatment. It is also important in providing guidance and recommendations about vaccination, management, biosecurity and the potential need for quarantine. Unwanted Horse Veterinary Relief Campaign Since 2009, every Merck Animal Health purchase you make helps equine rescue and retirement organizations keep their vaccination schedules up to date. Every time you purchase a product, we donate a portion to this worthy cause. This partnership between Merck Animal Health and the American Association of Equine Practitioners (AAEP) has delivered more than 21,000 doses of vaccine to horses in need, protecting their health and making them more adoptable. We re proud of our products, but we re also proud to be a part of this industry this group of people so passionate about horses. We show our love by making great products but also by contributing to overall equine health. We try to protect every horse from disease. Earl Gaughan, D.V.M., Dipl. ACVS Merck Animal Health

2 Giralda Farms Madison, NJ 07940 merck-animal-health-usa.com 800-521-5767 Copyright 2016 Intervet Inc., d/b/a/ Merck Animal Health, a subsidiary of Merck & Co., Inc. All rights reserved. 16-MERCK-3337-VACCINESTORY 800-521-5767 www.merck-animal-health-equine.com